DE69531709D1 - Derivate von Glycopeptid-Antibiotika - Google Patents

Derivate von Glycopeptid-Antibiotika

Info

Publication number
DE69531709D1
DE69531709D1 DE69531709T DE69531709T DE69531709D1 DE 69531709 D1 DE69531709 D1 DE 69531709D1 DE 69531709 T DE69531709 T DE 69531709T DE 69531709 T DE69531709 T DE 69531709T DE 69531709 D1 DE69531709 D1 DE 69531709D1
Authority
DE
Germany
Prior art keywords
derivatives
glycopeptide antibiotics
glycopeptide
antibiotics
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69531709T
Other languages
English (en)
Other versions
DE69531709T2 (de
Inventor
Robin David Grey Cooper
Bret Eugene Huff
Thalia Ioanna Nicas
John Thomas Quatroche
Michael John Rodriguez
Nancy June Snyder
Michael Alexander Staszak
Richard Craig Thompson
Stephen Charles Wilkie
Mark James Zweifel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of DE69531709D1 publication Critical patent/DE69531709D1/de
Publication of DE69531709T2 publication Critical patent/DE69531709T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69531709T 1994-01-28 1995-01-25 Derivate von Glycopeptid-Antibiotika Expired - Lifetime DE69531709T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US356413 1989-05-25
US18939394A 1994-01-28 1994-01-28
US35641394A 1994-12-15 1994-12-15
US189393 1998-11-10

Publications (2)

Publication Number Publication Date
DE69531709D1 true DE69531709D1 (de) 2003-10-09
DE69531709T2 DE69531709T2 (de) 2004-07-15

Family

ID=26885101

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69532013T Expired - Lifetime DE69532013T2 (de) 1994-01-28 1995-01-25 Glycopeptid-Antibiotika-Derivate
DE69531709T Expired - Lifetime DE69531709T2 (de) 1994-01-28 1995-01-25 Derivate von Glycopeptid-Antibiotika
DE69533004T Expired - Lifetime DE69533004T2 (de) 1994-01-28 1995-01-25 Derivate von Glycopeptid-Antibiotika

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69532013T Expired - Lifetime DE69532013T2 (de) 1994-01-28 1995-01-25 Glycopeptid-Antibiotika-Derivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69533004T Expired - Lifetime DE69533004T2 (de) 1994-01-28 1995-01-25 Derivate von Glycopeptid-Antibiotika

Country Status (30)

Country Link
US (1) US5843889A (de)
EP (3) EP1031576B1 (de)
JP (1) JP3756539B2 (de)
KR (1) KR100388867B1 (de)
CN (1) CN1071334C (de)
AT (3) ATE248856T1 (de)
AU (1) AU703106B2 (de)
BR (1) BR9500365A (de)
CA (3) CA2546910C (de)
CO (1) CO4600679A1 (de)
CZ (2) CZ292895B6 (de)
DE (3) DE69532013T2 (de)
DK (3) DK1016670T3 (de)
EG (1) EG25884A (de)
ES (3) ES2204444T3 (de)
FI (3) FI117095B (de)
HU (1) HU225164B1 (de)
IL (1) IL112457A (de)
MY (1) MY128335A (de)
NO (1) NO323103B1 (de)
NZ (1) NZ270387A (de)
PE (1) PE40996A1 (de)
PL (1) PL180961B1 (de)
PT (3) PT667353E (de)
RU (1) RU2145609C1 (de)
SG (1) SG52719A1 (de)
SI (2) SI0667353T1 (de)
TW (1) TW457248B (de)
UA (1) UA43323C2 (de)
YU (1) YU4995A (de)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
ID18900A (id) * 1996-11-21 1998-05-20 Lilly Co Eli Alkilasi menurun dari gliko peptida anti biotik
US5939382A (en) * 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
US5952466A (en) * 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5919771A (en) * 1997-05-20 1999-07-06 Eli Lilly And Company Urea and thiourea derivatives of glycopeptides
US5977063A (en) * 1997-05-20 1999-11-02 Eli Lilly And Company Alkylated hexapeptides
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
US5994297A (en) * 1997-08-22 1999-11-30 Eli Lilly And Company Therapy for Staphylococcus aureus
US6518242B1 (en) 1998-02-20 2003-02-11 Theravance, Inc. Derivatives of glycopeptide antibacterial agents
EP1073447B1 (de) 1998-05-01 2007-05-09 Eli Lilly And Company N1 modifizierte glycopeptide
US6710168B1 (en) * 1999-05-19 2004-03-23 The Trustees Of The University Of Princeton Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
JP2002520422A (ja) * 1998-07-14 2002-07-09 プリンストン ユニバーシティ グリコペプチド抗生物質、グリコペプチド抗生物質のコンビナトリアルライブラリーおよびその作成方法
CZ301184B6 (cs) 1998-12-23 2009-12-02 Theravance, Inc. Glykopeptidový derivát a farmaceutické prostredky, které jej obsahují
WO2001081373A2 (en) * 2000-04-25 2001-11-01 Merck & Co., Inc. Glycopeptide antibacterial compounds and methods of using same
AU2001259306A1 (en) 2000-05-02 2001-11-12 Advanced Medicine, Inc. Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin
US6770621B2 (en) 2000-05-02 2004-08-03 Theravance, Inc. Polyacid glycopeptide derivatives
CN100532392C (zh) * 2000-05-02 2009-08-26 施万制药 还原性烷基化方法
US6872804B2 (en) 2000-06-22 2005-03-29 Theravance, Inc. Glycopeptide disulfide and thioester derivatives
EP1292611B1 (de) 2000-06-22 2008-03-12 Theravance, Inc. Glykopeptidderivate mit carboxysacchariden
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
US6828299B2 (en) 2000-06-22 2004-12-07 Theravance, Inc. Polyhydroxy glycopeptide derivatives
TWI275594B (en) 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives
JP2006503015A (ja) * 2002-08-30 2006-01-26 カー・イュー・ルーベン・リサーチ・アンド・ディベロップメント グリコペプチド抗生物質誘導体
EP1624858B1 (de) 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Neue encochleationsverfahren
JP2006528704A (ja) 2003-05-27 2006-12-21 セラヴァンス インコーポレーテッド グリコペプチド抗細菌剤と組み合わせたポリエンマクロライド抗真菌剤の使用
DE602004010915T2 (de) 2003-07-22 2008-12-11 Theravance, Inc., South San Francisco Verwendung eines antimykotischen echinocandin-mittels in kombination mit einem antibakteriellen glycopeptid-mittel
EP1818340A4 (de) 2004-11-29 2009-02-25 Univ Nagoya Nat Univ Corp Antibiotische monomere glykopeptidderivate
US7632918B2 (en) 2005-02-28 2009-12-15 Novartis Vaccines And Diagnostics, Inc. Semi-synthetic glycopeptides with antibiotic activity
KR101474818B1 (ko) 2005-04-01 2014-12-19 부케예 테크놀로지스 인코포레이티드 방음용 부직포 재료 및 제조방법
CA2623239C (en) 2005-09-22 2016-07-12 Medivas, Llc Solid polymer delivery compositions and methods for use thereof
CA2623198C (en) 2005-09-22 2014-08-05 Medivas, Llc Bis-(a-amino)-diol-diester-containing poly(ester amide) and poly(ester urethane) compositions and methods of use
TW200808818A (en) 2006-05-26 2008-02-16 Shionogi & Co Glycopeptide antibiotic derivatives
CA2710417A1 (en) 2007-12-26 2009-07-02 Shionogi & Co., Ltd. Glycosylated glycopeptide antibiotic derivatives
EP2260060A4 (de) 2008-04-01 2013-01-16 Univ Cornell Organisch lösliche chitosansalze und daraus hergestellte chitosan-abgeleitete biomaterialien
CN101343313B (zh) * 2008-09-03 2011-11-16 南京农业大学 一种葡萄糖二肽类化合物及其制备方法和用途
WO2012151517A1 (en) 2011-05-05 2012-11-08 Coordinated Program Development, Llc Cochleate compositions and methods of making and using same
CN104418941B (zh) 2013-08-19 2017-11-07 爱斯医药科技(南京)有限公司 万古霉素衍生物、制备方法及其应用
US20160303184A1 (en) 2013-09-23 2016-10-20 Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) Vancomycin-sugar conjugates and uses thereof
MX2017000676A (es) * 2014-07-17 2018-01-11 The Medicines Co Oritavancina de alta pureza y metodo para producir la misma.
RS59851B1 (sr) 2014-11-06 2020-02-28 Xellia Pharmaceuticals Aps Kompozicije glikopeptida
EP3240574A1 (de) * 2014-12-25 2017-11-08 Jawaharlal Nehru Centre For Advanced Scientific Research Glykopeptide und verwendungen davon
CN106188243B (zh) * 2015-05-05 2020-06-26 博瑞生物医药（苏州）股份有限公司 一种奥利万星的制备方法
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN107434823B (zh) * 2016-05-26 2021-11-16 江苏恒瑞医药股份有限公司 一种奥利万星中间体a82846b的纯化方法
CN108409837B (zh) * 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用
CN109053864B (zh) * 2018-07-10 2021-08-24 丽珠集团新北江制药股份有限公司 一种制备奥利万星的方法
CN109053865B (zh) * 2018-07-20 2021-04-13 丽珠集团新北江制药股份有限公司 一种羧基保护制备奥利万星的方法
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
US3338786A (en) * 1966-07-29 1967-08-29 American Cyanamid Co Antibiotic av290 and production thereof
US4552886A (en) * 1982-06-07 1985-11-12 Eli Lilly And Company Fungicidal pyridylmethyl-amines
IT1173329B (it) * 1984-02-21 1987-06-24 Lepetit Spa Procedimento per la trasformazione quantitativa di teicoplanina a2 fattore 1 in teicoplanina a2 fattore 3
GB8415093D0 (en) * 1984-06-13 1984-07-18 Lepetit Spa Antibiotic l 17392
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
US4639433A (en) * 1985-08-14 1987-01-27 Eli Lilly And Company Glycopeptide derivatives
US4946941A (en) * 1986-01-24 1990-08-07 Shionogi & Co., Ltd. Novel glycopeptide antibiotics
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
GB8701872D0 (en) * 1987-01-28 1987-03-04 Lepetit Spa N15-alkyl & n15,n15-dialkyl derivatives
US5071749A (en) * 1987-04-16 1991-12-10 Shionogi & Co., Ltd. Glycopetide antibiotic pa-45052-b
GB8726859D0 (en) * 1987-11-17 1987-12-23 Lepetit Spa 22-dechlorotei-coplanins
PT90366A (pt) * 1988-04-28 1989-11-10 Beecham Group Plc Processo para a producao de compostos glicopeptidicos
CA1339808C (en) * 1988-10-19 1998-04-07 Manuel Debono Glycopeptide antibiotics
US5194424A (en) * 1988-12-27 1993-03-16 Gruppo Lepetit Spa C63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deoxy-teicoplanin and their use as medicaments against bacteria resistant to glycopeptide antibiotics
US5185320A (en) * 1989-04-03 1993-02-09 Gruppo Lepetit S.P.A. O56 -alkyl derivatives of aglycone and pseudo aglycones of teicoplanin
ATE87502T1 (de) * 1989-12-11 1993-04-15 De Beers Ind Diamond Schleifprodukte.
NZ236393A (en) * 1989-12-13 1992-05-26 Lilly Co Eli N-alkylated glycopeptide derivatives prepared from antibiotics a82846 series and pa-42867-a; pharmaceutical compositions
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
WO1993003060A1 (en) * 1991-07-29 1993-02-18 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic a 40926

Also Published As

Publication number Publication date
SG52719A1 (en) 1998-09-28
YU4995A (sh) 1998-07-10
MY128335A (en) 2007-01-31
FI950374A0 (fi) 1995-01-27
KR100388867B1 (ko) 2003-10-08
CA2141106C (en) 2007-01-23
DE69533004D1 (de) 2004-06-09
CZ292921B6 (cs) 2004-01-14
DE69531709T2 (de) 2004-07-15
FI20050513A (fi) 2005-05-13
RU95101039A (ru) 1996-10-27
CZ292895B6 (cs) 2003-12-17
ES2220335T3 (es) 2004-12-16
NO950298L (no) 1995-07-31
UA43323C2 (uk) 2001-12-17
US5843889A (en) 1998-12-01
CA2546625C (en) 2008-09-09
EP1031576A2 (de) 2000-08-30
NO950298D0 (no) 1995-01-26
PT1031576E (pt) 2004-08-31
EP1031576B1 (de) 2004-05-06
PT1016670E (pt) 2003-12-31
AU703106B2 (en) 1999-03-18
RU2145609C1 (ru) 2000-02-20
IL112457A (en) 2004-06-20
EP0667353A1 (de) 1995-08-16
CA2141106A1 (en) 1995-07-29
EP1016670B1 (de) 2003-09-03
TW457248B (en) 2001-10-01
DE69532013T2 (de) 2004-07-08
CA2546910C (en) 2010-09-14
AU1138995A (en) 1995-08-10
EG25884A (en) 2012-09-24
FI117096B (fi) 2006-06-15
JPH07258289A (ja) 1995-10-09
BR9500365A (pt) 1995-10-17
CO4600679A1 (es) 1998-05-08
FI950374A (fi) 1995-07-29
PL306976A1 (en) 1995-08-07
ATE266042T1 (de) 2004-05-15
EP1031576A3 (de) 2000-12-27
SI1016670T1 (en) 2004-02-29
DK1016670T3 (da) 2004-01-05
FI117097B (fi) 2006-06-15
EP1016670A1 (de) 2000-07-05
NO323103B1 (no) 2007-01-02
PE40996A1 (es) 1996-10-14
FI20050512A (fi) 2005-05-13
EP0667353B1 (de) 2003-10-29
DK0667353T3 (da) 2004-03-22
HU9500230D0 (en) 1995-03-28
DE69532013D1 (de) 2003-12-04
CN1071334C (zh) 2001-09-19
JP3756539B2 (ja) 2006-03-15
SI0667353T1 (en) 2004-04-30
KR950032274A (ko) 1995-12-20
CA2546910A1 (en) 1995-07-29
HUT68715A (en) 1995-07-28
ES2210274T3 (es) 2004-07-01
CZ18495A3 (en) 1995-08-16
FI117095B (fi) 2006-06-15
ES2204444T3 (es) 2004-05-01
PL180961B1 (pl) 2001-05-31
CA2546625A1 (en) 1995-07-29
CN1119649A (zh) 1996-04-03
PT667353E (pt) 2004-03-31
ATE253077T1 (de) 2003-11-15
NZ270387A (en) 1996-11-26
ATE248856T1 (de) 2003-09-15
HU225164B1 (en) 2006-07-28
DE69533004T2 (de) 2005-04-07
DK1031576T3 (da) 2004-08-16
IL112457A0 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
ATE248856T1 (de) Derivate von glycopeptid-antibiotika
GB2238962B (en) Dual source intravenous adminstration set having an intravenous pump
IT1285770B1 (it) Composti corticoidei
DE3780644D1 (de) Glykopeptid-antibiotika.
RU95101041A (ru) Липосомные растворы
DE69010924D1 (de) Antibiotikum L53-18A und dessen Herstellung.
ATE66610T1 (de) Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako- kosmetische kompositionen.
IT1207578B (it) Antibiotici carbapenem e relativo procedimento di preparazione.
DK387287A (da) Glycopeptidantibiotika
FI930378A (fi) Fosfenoxidavslutade allen-en-yn dna-spjaelkande, antitumoer och antibiotika molekyler
TR199701334T1 (xx) Antibakteriyel antibiyotikler.
GR920100423A (el) Ανταγωνιστές 5-ΗΤ4 κινολιζιδινυλ εστέρος.
DE59609353D1 (de) Mittel zur subkutanen Verabreichung von Protein C

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN